<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26468183</article-id>
<article-id pub-id-type="pmc">4604222</article-id>
<article-id pub-id-type="publisher-id">2656-15</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.2656-15.2015</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Symposium and Mini-Symposium</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Huber</surname>
<given-names>Kimberly M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klann</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Costa-Mattioli</surname>
<given-names>Mauro</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zukin</surname>
<given-names>R. Suzanne</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75390, </aff>
<aff id="aff2"><sup>2</sup>Center for Neural Science, New York University, New York, New York 10003, </aff>
<aff id="aff3"><sup>3</sup>Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, and </aff>
<aff id="aff4"><sup>4</sup>Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, New York 10461</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. R. Suzanne Zukin,
<addr-line>Dominick P. Purpura Department of Neuroscience, Rose F. Kennedy Center, Room 610, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461.</addr-line><email>suzanne.zukin@einstein.yu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>14</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>4</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>35</volume>
<issue>41</issue>
<fpage>13836</fpage>
<lpage>13842</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2015 the authors 0270-6474/15/3513836-07$15.00/0</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri xlink:href="zns04115013836.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.</p>
</abstract>
<kwd-group>
<kwd>mTOR signaling</kwd>
<kwd>Fragile X syndromes</kwd>
<kwd>protein synthesis pathway</kwd>
<kwd>mouse models of autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>